|
2025
|
Invention
|
Pharmaceutical compounds and compositions as modulators of mas-related g-protein receptor x2. The... |
|
|
Invention
|
Pharmaceutical compounds and compositions as modulators of mas-related g-protein receptor x2.
Th... |
|
|
Invention
|
Benzodiazepine derivatives as rsv inhibitors.
The present invention discloses compounds of Formu... |
|
|
Invention
|
Fused heterobicyclic antiviral agents.
The present invention discloses compounds of Formula (I),... |
|
|
Invention
|
Fused heterobicyclic antiviral agents. The present invention discloses compounds of Formula (I), ... |
|
|
Invention
|
Pharmaceutical compounds and compositions as c-kit kinase inhibitors.
The invention provides com... |
|
2024
|
Invention
|
Crystal forms of an anti-rsv agent. The present invention features crystalline forms of Compound ... |
|
|
Invention
|
Crystal forms of an anti-rsv agent.
The present invention features crystalline forms of Compound... |
|
|
Invention
|
Pyrimidinone-containing 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors. The present inve... |
|
|
Invention
|
17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof.
The present ... |
|
|
Invention
|
17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof. The present i... |
|
|
Invention
|
Processes for the preparation of oxadiazolylamino benzodiazepine derivatives.
The present invent... |
|
|
Invention
|
Processes for the preparation of oxadiazolylamino benzodiazepine derivatives. The present inventi... |
|
|
Invention
|
Pharmaceutical compounds and compositions as c-kit kinase inhibitors. The invention provides comp... |
|
|
Invention
|
Compounds and compositions as c-kit kinase inhibitors.
The invention provides compounds of formu... |
|
|
Invention
|
Compounds and compositions as c-kit kinase inhibitors. The invention provides compounds of formul... |
|
|
Invention
|
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof.
The present inventio... |
|
|
Invention
|
Hepatitis b antiviral agents.
The present invention discloses compounds of Formula (I), or pharm... |
|
|
Invention
|
Antiviral heterocyclic compounds.
The present invention discloses compounds of Formula (I), or p... |
|
|
Invention
|
Antiviral heterocyclic compounds. The present invention discloses compounds of Formula (I), or ph... |
|
|
Invention
|
Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof.
The present invention pro... |
|
|
Invention
|
Fused heterotetracyclic antiviral agents.
The present invention discloses compounds of Formula (... |
|
|
Invention
|
Fused heterotetracyclic antiviral agents. The present invention discloses compounds of Formula (I... |
|
|
Invention
|
Benzodiazepine derivatives as rsv inhibitors. The present invention discloses compounds of Formul... |
|
2023
|
Invention
|
Covalent inhibitors as antiviral agents.
The present invention discloses compounds of Formula (I... |
|
|
Invention
|
Novel covalent inhibitors as antiviral agents. The present invention discloses compounds of Formu... |
|
|
Invention
|
Functionalized heterocycles as antiviral agents. The present invention discloses compounds of For... |
|
|
Invention
|
Macrocyclic chalcone-amide derived antiviral agents.
The present invention discloses compounds o... |
|
|
Invention
|
Novel macrocyclic chalcone-amide derived antiviral agents. The present invention discloses compou... |
|
|
Invention
|
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof. ... |
|
|
Invention
|
Crystal forms of an anti-sars cov-2 agent.
The present invention features crystalline forms of C... |
|
|
Invention
|
Crystal forms of an anti-sars cov-2 agent. The present invention features crystalline forms of Co... |
|
|
Invention
|
Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof. The present invention prov... |
|
|
Invention
|
Pyrimidinone-containing 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors.
The present inv... |
|
|
Invention
|
Antiviral compounds. The present invention discloses compounds of Formula (I), or pharmaceuticall... |
|
|
Invention
|
Antiviral heterocyclic compounds. The present invention discloses compounds of Formula (I), and p... |
|
|
Invention
|
Spiropyrrolidine derived antiviral agents. The present invention discloses compounds of Formula (... |
|
|
Invention
|
Novel spiropyrrolidine derived antiviral agents. The present invention discloses compounds of For... |
|
2022
|
P/S
|
Pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical a... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of viral
infections and hepatic diseases and disor... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of viral infections and hepatic diseases and disord... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of viral infections and hepatic diseases and disorders |
|
2002
|
P/S
|
research and development services in the field of identification of compounds as potential therap... |
